Subscribe to Our Newsletter
Top Small Cap Market News
- $ANPC Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
- $FLGC Kicks off 2022 with Successful First Cannabis Extraction at new Colombia Facility, the Appointment of Tim Leslie as Advisory Board Chairman, and 360 Financial Inc.’s FLGC stock purchase
- $FLGC Appoints Renowned Genetics, Cultivation Expert as Advisor
- $GCAC Cepton Technologies Inc. Merger to Be Discussed at Upcoming Investor Day
- $NMRD Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution
- $RWBYF 420 with CNW – SAFE Banking Act Sponsor Vows to See Bill Passed Before He Retires
- $SVFD Announces Partnership with Israel’s Second Largest Exporter of Fresh Produce
- $CNSP Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement
- $IWBB CEO Featured in The Daily Helping Podcast Interview
- $UUUU Uranium’s Bull Run Triggers Investment in Exploration
- $UUUU Much Maligned Uranium Could Save the Planet
- $GBOX Announces Staggering 800% Increase in 2021 Processing Volume
Bull of the Week
Growth Capital Acquisition Corp.
(NASDAQ: GCAC)
Growth Capital Acquisition Corp. (NASDAQ: GCAC), a publicly traded special purpose acquisition company listed on February 2, 2021, with $172.5 million in Trust, and Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance MMT® lidar solutions, on August 5, 2021, announced their entry into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed ‘Cepton Inc.’ and is expected to be listed on the Nasdaq stock exchange under new ticker symbol ‘CPTN’. The proposed business combination, which has been unanimously approved by the boards of directors of Cepton and Growth Capital, is expected to be completed early in the first quarter of 2022, subject to, among other things, approval by Growth Capital’s stockholders, satisfaction of the conditions stated in the definitive agreement and other customary closing conditions. ContinueTraderPower Featured Stocks
- AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Cybin Inc. (NYSE American: CYBN) (NEO: CYBN)
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)
- Excellon Resources Inc. (NYSE American: EXN) (TSX: EXN) (FSE: E4X2)
- Flora Growth Corp. (NASDAQ: FLGC)
- FingerMotion Inc. (OTCQX: FNGR)
- GreenBox POS (NASDAQ: GBOX)
- Growth Capital Acquisition Corp. (NASDAQ: GCAC)
- InMed Pharmaceuticals Inc. (NASDAQ: INM)
- Kaival Brands Innovations Group Inc. (NASDAQ: KAVL)
- Lexaria Bioscience Corp. (NASDAQ: LEXX)
- Mullen Automotive Inc. (NASDAQ: MULN)
- Nemaura Medical Inc. (NASDAQ: NMRD)
- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF)
- Pressure BioSciences Inc. (PBIO)
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF)
- SRAX Inc. (NASDAQ: SRAX)
- Save Foods Inc. (NASDAQ: SVFD)
- Tingo Inc. (OTCQB: IWBB)